Recommended Pages at library.nhs.uk
NHS Evidence Health Information Resources formerly National Library for Health - News & RSS Article
library.nhs.uk — “NHS Evidence Health Information Resources formerly National Library for Health - News & RSS Article” View full resource at library.nhs.uk
Most Recently Shared on March 26, 2011 at 3:14 am By:
Annual Evidence Update on Multiple Sclerosis: 28 March - 1 April 2011: An update of the evidence on this topic f... http://bit.ly/h1XkuM
NHS Evidence - Neurological conditions - Letter: Variant CreutzfeldteJakob disease occurring in mother and son
library.nhs.uk — “Bibliographic details: Riverol M, Palma JA, Alana M, Guerrero-Marquez, Roario Luquin M, Rabano A. (2011) Variant Variant CreutzfeldteJakob disease occurring in mother and son. Journal of Neurology, Neurosurgery and Psychiatry with Practical Neurology Online First February 22, 2011 Introduction: Variant CreutzfeldteJakob disease (vCJD) is distinguished from sporadic CJD by a number of characteristics, including a causal association with bovine spongiform encephalopathy (BSE) prions mainly through” View full resource at library.nhs.uk
Most Recently Shared on March 24, 2011 at 12:27 am By:
Letter: Variant CreutzfeldteJakob disease occurring in mother and son: (Source: NHS Evidence - Neurological cond... http://bit.ly/f8GZfr
NHS Evidence - Neurological conditions - Pharmacoeconomic considerations in the treatment of multiple sclerosis
library.nhs.uk — “Bibliographic details: Sharac J, McCrone P, Sabes-Figuera R. (2010) Pharmacoeconomic considerations in the treatment of multiple sclerosis. Drugs 70(13):1677-1691 Multiple sclerosis (MS) is a disorder that incurs high costs to individuals, health systems and society as a whole. A growing number of studies have measured the costs of MS and assessed the cost effectiveness of different treatments. This review summarizes the evidence from these studies. Electronic databases were searched and a total” View full resource at library.nhs.uk
Most Recently Shared on March 19, 2011 at 1:39 am By:
Pharmacoeconomic considerations in the treatment of multiple sclerosis: A growing number of studies have measure... http://bit.ly/hEGHaQ
NHS Evidence - UK Database of Uncertainties about the Effects of Treatments (DUETs) - Vitamin D for multiple sclerosis
library.nhs.uk — “The Database of Uncertainties about the Effects of Treatments (DUETs) assembles and publishes uncertainties about the effects of treatments which cannot currently be answered by referring to reliable, up-to-date systematic reviews of existing research evidence. Because inadequately evaluated treatments can do more good than harm, uncertainties about the effects of treatments must be identified and those deemed sufficiently important addressed in research.” View full resource at library.nhs.uk
Most Recently Shared on March 10, 2011 at 11:53 pm By:
DUET - Vitamin D for multiple sclerosis: The evidence from this review does not at present allow confident decis... http://bit.ly/iicznx
NHS Evidence - UK Database of Uncertainties about the Effects of Treatments (DUETs) - Daclizumab for relapsing remitting multiple sclerosis
library.nhs.uk — “The Database of Uncertainties about the Effects of Treatments (DUETs) assembles and publishes uncertainties about the effects of treatments which cannot currently be answered by referring to reliable, up-to-date systematic reviews of existing research evidence. Because inadequately evaluated treatments can do more good than harm, uncertainties about the effects of treatments must be identified and those deemed sufficiently important addressed in research.” View full resource at library.nhs.uk
Most Recently Shared on March 10, 2011 at 11:53 pm By:
DUET - Daclizumab for relapsing remitting multiple sclerosis: Monoclonal antibodies such as daclizumab could be ... http://bit.ly/fA24PK
NHS Evidence - UK Database of Uncertainties about the Effects of Treatments (DUETs) - Hyperbaric oxygen therapy for multiple sclerosis
library.nhs.uk — “The Database of Uncertainties about the Effects of Treatments (DUETs) assembles and publishes uncertainties about the effects of treatments which cannot currently be answered by referring to reliable, up-to-date systematic reviews of existing research evidence. Because inadequately evaluated treatments can do more good than harm, uncertainties about the effects of treatments must be identified and those deemed sufficiently important addressed in research.” View full resource at library.nhs.uk
Most Recently Shared on March 10, 2011 at 11:53 pm By:
DUET - Hyperbaric oxygen therapy for multiple sclerosis: We found no consistent evidence to confirm a beneficial... http://bit.ly/ihg2yk
NHS Evidence - Neurological conditions - Psoriasis and multiple sclerosis: is there a link?
library.nhs.uk — “Citation: Kwok T, Jing Loo W, Guenther L. (2010) Psoriasis and multiple sclerosis: is there a link? Journal of Cutaneous Medicine and Surgery 14(4):151-5 Background: Psoriasis and multiple sclerosis (MS) are both autoimmune T cell-mediated diseases. Some case series have suggested an association. Objectives: To investigate the potential relationship between psoriasis and MS based on a systematic review of the literature. Methodology: Medline, Cochrane Library, and EMBASE searches were performed.” View full resource at library.nhs.uk
Most Recently Shared on March 5, 2011 at 7:07 am By:
Psoriasis and multiple sclerosis - is there a link: Objectives: To investigate the potential relationship betwee... http://bit.ly/fEYKfi
NHS Evidence - Neurological conditions - Psychosocial adjustment in children and adolescents with a parent with multiple sclerosis
library.nhs.uk — “Citation: Bogosian A, Moss-Morris R, Hadwin J. (2010) Psychosocial adjustment in children and adolescents with a parent with multiple sclerosis. Clinical Rehabilitation 24(9):789-801 Objective: This systematic review explored the potential impact of parental multiple sclerosis on their offspring. It considered adjustment to parental multiple sclerosis at different developmental stages and the factors associated with good versus poor adjustment. Data sources: MEDLINE, EMBASE, PsycINFO, CINAHL and” View full resource at library.nhs.uk
Most Recently Shared on March 4, 2011 at 11:11 pm By:
Psychosocial adjustment in children and adolescents with a parent with multiple sclerosis: Objective: This syste... http://bit.ly/hB7SfA
NHS Evidence - Neurological conditions - Economic burden of multiple sclerosis: A systematic review of the literature
library.nhs.uk — “Citation: Naci H, Fleurence R, Birt J, Duhig A. (2010) Economic burden of multiple sclerosis: A systematic review of the literature. Pharmacoeconomics 28(5):363-79 Abstract: Multiple sclerosis (MS) is a disease of the CNS, typically striking adults during the primary productive time of their life. The symptoms of MS can restrict the individual's physical activity and income-earning ability, resulting in a major financial burden on the patient, family, health system and society. This systematic l” View full resource at library.nhs.uk
Most Recently Shared on March 4, 2011 at 11:11 pm By:
Economic burden of multiple sclerosis - A systematic review of the literature: This systematic literature review... http://bit.ly/eZEyNk
NHS Evidence - Neurological conditions - The impact of increasing neurological disability of multiple sclerosis on health utilities: a systematic review of the literature
library.nhs.uk — “Citation: Naci H, Fleurence R, Birt J, Duhig A. (2010) The impact of increasing neurological disability of multiple sclerosis on health utilities: a systematic review of the literature. Journal of Medical Economics 13(1):78-89 Background: Multiple sclerosis (MS) is a debilitating disease, accompanied by neurological symptoms of varying severity. Utilities are a key summary index measure used in assessing health-related quality of life in individuals with MS. Objectives: To provide a systematic r” View full resource at library.nhs.uk
Most Recently Shared on March 4, 2011 at 11:11 pm By:
The impact of increasing neurological disability of multiple sclerosis on health utilities - a systematic review... http://bit.ly/gy0ycY
NHS Evidence - Neurological conditions - Multiple sclerosis and risk of cancer: a meta-analysis
library.nhs.uk — “Citation: Handel AE, Ramagopalan SV. (2010) Multiple sclerosis and risk of cancer: a meta-analysis. Journal of Neurology, Neurosurgery and Psychiatry with Practical Neurology 81(12):1413-1414 There is no formal abstract for this paper as it is a meta-analysis published within a letter. Link to the full text here.” View full resource at library.nhs.uk
Most Recently Shared on March 2, 2011 at 4:29 am By:
Multiple sclerosis and risk of cancer - a meta-analysis: There is no formal abstract for this paper as it is a m... http://bit.ly/fD4A6y
NHS Evidence - Neurological conditions - Nocebo effects in multiple sclerosis trials: a meta-analysis
library.nhs.uk — “Citation: Papadopoulos D, Mitsikostas DD. (2010) Nocebo effects in multiple sclerosis trials: a meta-analysis. Multiple Sclerosis Journal 2010 16(7):816-828 Objective: To estimate the incidence and severity of nocebo responses in trials of symptomatic treatments (STs) and disease-modifying treatments (DMTs) for multiple sclerosis (MS). Methods: We conducted a systematic Medline search for all randomised, placebo-controlled MS trials published between 1989 and 2009. Meta-analysis of the incidence” View full resource at library.nhs.uk
Most Recently Shared on March 2, 2011 at 4:29 am By:
Nocebo effects in multiple sclerosis trials - a meta-analysis: Objective: To estimate the incidence and severity... http://bit.ly/fM2Zxr
NHS Evidence - Neurological conditions - Relation between Epstein-Barr virus and multiple sclerosis: analytic study of scientific production
library.nhs.uk — “Citation: Santiago O, Gutierrez J, Sorlozano A, de Dios Luna J, Villegas E, Fernandez O. (2010) Relation between Epstein-Barr virus and multiple sclerosis: analytic study of scientific production. European Journal of Clinical Microbiology and Infectious Diseases 29(7):857-66 Abstract: Numerous studies have been carried out to determine whether infection by the Epstein-Barr virus (EBV) can be considered as a risk factor for multiple sclerosis (MS). This work is a meta-analysis of case-control obs” View full resource at library.nhs.uk
Most Recently Shared on March 2, 2011 at 4:29 am By:
Relation between Epstein-Barr virus and multiple sclerosis - analytic study of scientific production: This work ... http://bit.ly/fGjU57
NHS Evidence - Gastroenterology and liver diseases - Commissioning Guide: Biologic drugs for the treatment of inflammatory disease in rheumatology, dermatology and gastroenterology
library.nhs.uk — “Aims: This commissioning guide provides support for the local implementation of NICE guidance through commissioning, and is a resource for people involved in commissioning health and social care services and public health programmes within the NHS and partner organisations in England. Although this guide focuses on commissioning biologic drugs for the treatment of inflammatory disease, commissioners should also be aware that they may need to commission biologic drugs for a range of other conditi” View full resource at library.nhs.uk
Most Recently Shared on March 1, 2011 at 9:04 pm By:
allergydropz Surgeon, ENT Doctor, Physician, and Doctor
Medworm: Commissioning Guide: Biologic drugs for the treatment of inflammatory disease http://bit.ly/haIytM Full http://bit.ly/fYA0AW
NHS Evidence - Neurological conditions - Pharmacologic treatment of depression in multiple sclerosis
library.nhs.uk — “Background Depression is a common problem in patients with multiple sclerosis (MS). It is unclear which pharmacologic treatment is the most effective and the least harmful. Objectives To investigate the efficacy and tolerability of pharmacologic treatments for depression in patients with MS. Search strategy We searched the Cochrane Multiple Sclerosis Group's Trials Register (June 2010), reference lists of relevant articles and conference proceedings. Regulatory agencies were used as additional s” View full resource at library.nhs.uk
Most Recently Shared on March 1, 2011 at 4:26 am By:
Pharmacologic treatment of depression in multiple sclerosis: Objectives: To investigate the efficacy and tolerab... http://bit.ly/fCZR1e
